Cart
sales@molnova.com
PF-4776548
CAS No. 1515856-61-7
PF-4776548( PF-04776548 )
Catalog No. M12117 CAS No. 1515856-61-7
PF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-4776548
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-04776548
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1515856-61-7
-
Formula Weight341.342
-
Molecular FormulaC18H16FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(3-(4-fluoro-2-methoxy-benzyl)-7-hydroxy-8,9-dihydro-3H,7H-pyrrolo[2,3-c][1,7]naphthyridin-6-one)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harrison A, et al. Xenobiotica. 2012 Jan;42(1):57-74.
molnova catalog
related products
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
-
NBD-14189
NBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63?nM against some clinical isolates.
-
Elvitegravir
Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.
